Period Ending | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
---|---|---|---|---|
Total Revenue | 2,841,856 | 1,483,794 | 1,657,421 | 1,756,262 |
Cost of Revenue | 2,383,202 | 1,225,952 | 1,367,196 | 1,437,524 |
Gross Profit | 458,654 | 257,842 | 290,225 | 318,738 |
Operating Expenses | ||||
Research Development | -- | -- | -- | -- |
Selling General and Administrative | 133,602 | 58,295 | 67,137 | 66,330 |
Non Recurring | -- | -- | -- | -- |
Others | 287,944 | 182,891 | 157,510 | 162,686 |
Total Operating Expenses | 421,546 | 241,186 | 224,647 | 229,016 |
Operating Income or Loss | 37,108 | 16,656 | 65,578 | 89,722 |
Income from Continuing Operations | ||||
Total Other Income/Expenses Net | (43,718) | (611) | (1,746) | (3,391) |
Earnings Before Interest And Taxes | 67,882 | 23,058 | 69,342 | 93,921 |
Interest Expense | -- | -- | -- | -- |
Income Before Tax | (4,722) | (18,095) | 30,472 | 60,177 |
Income Tax Expense | -- | 4,535 | 7,673 | 14,949 |
Minority Interest | 53,488 | 29,982 | 31,213 | 28,311 |
Net Income From Continuing Ops | (4,722) | (22,630) | 22,799 | 45,228 |
Non-recurring Events | ||||
Discontinued Operations | -- | -- | -- | -- |
Extraordinary Items | -- | -- | -- | -- |
Effect Of Accounting Changes | -- | -- | -- | -- |
Other Items | (92) | 2,854 | (2,902) | (2,666) |
Net Income | (4,814) | (19,776) | 19,897 | 42,562 |
Preferred Stock And Other Adjustments | -- | -- | -- | -- |
Net Income Applicable To Common Shares | (4,814) | (19,776) | 19,897 | 42,562 |